Current funding opportunities

You are here

We are now accepting applications for the Committee for Pharmaceutical Development (CPD) and the TTR Core Usage Funding Program.

Committee for Pharmaceutical Development (CPD) 

Deadline
N/A (applications accepted on a continuous basis)
 
Program overview
The goal of the Committee for Pharmaceutical Development (CPD) is to identify, develop, and commercialize pharmaceutical products by forming networks and fostering dialogue between University of Minnesota researchers and industry experts. The CPD aims to boost the success rate of therapeutic development and commercialization.
 
The Office of the Vice President for Research and the Office of the Vice President for Health Sciences serve as the sponsors of the CPD, which includes University staff and external advisors with proven drug-development experience.
 
The CPD provides guidance and funding, with potential matching funds from philanthropic and industry partners. Funded technologies will have demonstrated persuasive indicators of commercial success and will show potential for improving human health.

Application instructions

Funding request form
Guidance request form

Please submit forms to the Program Manager, Jodi Fenlon Rebuffoni, at fenl0003@umn.edu.

 

TTR Core Usage Funding Program

Deadline
Due the 10th of any month

Program overview
The ongoing Core Usage Funding Program provides quick access to funding to use the Translational Technologies and Resources (TTR)-designated Core Resources. Nine eligible Core Resources are identified on the RFA. Applicants may request up to $10,000 to use a TTR-designated Core Resource for up to one year.

The PI must consult with the appropriate Core Director to discuss feasibility, cost, and a timeline prior to submitting an application. Please review the RFA for additional considerations. This funding supports research to advance medical knowledge that can improve human health.

This funding opportunity is open to PIs who hold a faculty-level appointment, Assistant Professor or higher. A direct or clear link to human health or disease must be provided for proposals that include animal models or in vitro culture systems.

Applications are due by 5:00 p.m. on the 10th day of any month. Funding decisions are communicated to the PI on the 10th day of the month following the application.

Application instructions
Download the RFA
for more information about the application process.

  • © 2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer. Privacy
  • Last modified on September 16, 2014